US Patent Issued to Cedars-Sinai Medical Center, Vanderbilt University on March 31 for "Palmitoyl protein biomarkers in purified extracellular vesicles for early identification of clinically significant prostate cancer" (California, Tennessee Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,965, issued on March 31, was assigned to Cedars-Sinai Medical Center (Los Angeles) and Vanderbilt University (Nashville, Tenn.).

"Palmitoyl protein biomarkers in purified extracellular vesicles for early identification of clinically significant prostate cancer" was invented by Dolores Di Vizio (Los Angeles), Wei Yang (Studio City, Calif.), Javier Mariscal Avila (Los Angeles), Tatyana Vagner (Los Angeles), Sungyong You (Los Angeles) and Andries Zijlstra (Nashville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides for methods for isolating large EVs and detecting palmitoyl proteins in the large EVs, as well as methods for d...